Fresenius SE & Co KGaA/ DE0005785604 /

7/16/2019 5:29:07 PM	Chg. +0.14	Volume	Bid5:30:00 PM	Ask5:30:00 PM	Market Capitalization	Dividend Y.	P/E Ratio
46.93EUR	+0.30%	63,412 Turnover: 2.98 mill.	46.90Bid Size: 70	46.98Ask Size: 107	26.11 bill.EUR	1.70%	12.86

GlobeNewswire 7/16/2018 OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada

GlobeNewswire 2/21/2018 Global Kidney Dialysis Equipment and Supplies Markets 2016-2024: Fresenius and Baxter Dominate the M...

TeleTrader 8/7/2017 Fresenius Medical buys NxStage for $2 billion

GlobeNewswire 7/19/2017 Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi

GlobeNewswire 6/9/2017 KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

GlobeNewswire 4/7/2017 Akorn Confirms Discussions with Fresenius Kabi

GlobeNewswire 1/27/2011 Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®